… and coronary artery disease, which together account for HF development in more than 50%
of cases, as well as chronic obstructive pulmonary disease (COPD), chronic kidney disease, …

… mice is one of the key factors responsible for amplifying muscle wasting in this model [83]. …
in DM1 patients with acutely severe muscle wasting, compared to more stable patients [45]. …

… disease were the main relevant comorbidities of elderly Chinese RA patients in our study.
Muscle wasting is … mortality, in various diseases, such as cardiovascular diseases, respiratory …

… Thus, it is generally accepted that frailty and sarcopenia, as well as physical function are
predictors of survival in patients with cardiovascular diseases (CVD), and they increase the risk …

… muscle wasting, presence of edema and loss of subcutaneous fat. Based on these assessments,
each patient was given a score that reflects the nutritional status as follows: 1 = normal …

… , while at the same time, skeletal muscle wasting is expressed as a decrease in body weight
… greater than that calculated as extracellular fluid because of the decrease in muscle weight. …

… a common complication of various cardiac diseases, and its … in the treatment of coronary
artery disease. As HF patients age… , muscle wasting, because muscle wasting causes elevation …

… and emerging therapeutic approaches to treat muscle wasting in COPD, including a … for
muscle atrophy in other pathological states that could be of relevance for treating muscle wasting …

… Indeed, depending on the specific condition, muscle wasting may be due to the inflammatory
factors present at high levels in a given disease state plus the secondary sarcopenia due to …

… Protein-energy wasting (PEW) is prevalent in dialysis patients, and cardiovascular disease
(… Muscle wasting: reduced muscle mass 5% over 3 months or 10% over 6 months* Reduced …